COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The global antimicrobial additives market size is anticipated to reach USD 3.62 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.0% over the forecast period. Rising demand from various end-use industries, such as healthcare, packaging, and food and beverage is driving the market growth. These three end-use industries accounted for a market share of 65.9% in terms of revenue in 2017.

Antimicrobial additives are increasingly used in the production of medical devices such as sheaths, guidewires, access systems, guiding catheters, diagnostic catheters, and thrombectomy devices to prevent the microbial growth. High occurrence of diseases coupled with geriatric population, sedentary lifestyle, and unhealthy dietary habits can further fuel demand for these devices, which in turn is anticipated to stimulate the market growth.

Inorganic additives are expected to gain significant prominence over the years to come owing to their use in a broader range of materials and applications, including paints, coatings, textiles, and polymers over organic additives. They also have excellent protection capabilities. For instance inorganic additives, such as copper salts provide antimicrobial protection in preservative and sterilized applications, with underlying substrates or layers being paints, coatings, and polymers.

Asia Pacific is estimated to be the fastest growing region during the forecast period. Rapidly growing healthcare sector and dominant packaging industry are expected to propel the product utilization in the region. The U.S. has been a significant consumer of antimicrobial additives on a global scale for many years. High demand for advanced medical services due to the availability of reimbursement coverage and actively developed healthcare infrastructure are some of the factors driving the market growth in the healthcare segment.

Competitive landscape of the antimicrobial additives market reflects a number of companies currently investing in research & development of new products to enhance their market position. Since the past few years, there has been a considerable increase in product innovation.

Further key findings from the report suggest:

  • Healthcare is anticipated to be the fastest growing end-use segment. It is anticipated to register a CAGR of 11.1% during the forecast period, in terms of revenue, on account of increasing manufacturing of medical devices
  • Plastics segment captured the highest market share of 35.0%, in terms of revenue, in 2017. Extensive use in soap dispensers, food containers, surgical products, and breathing devices is anticipated to drive the demand over the forecast period
  • The antimicrobial additives output in Asia Pacific is estimated to expand at the fastest CAGR of 10.0% during the forecast period with China and India being the top markets
  • Inorganic additives are predicted to account for a market share of 55.9% in terms of volume by 2025. Significant demand for silver-based, copper-based, and zinc-based additives is anticipated to drive the segment in the forthcoming years
  • Key companies operating in the antimicrobial additives market are NanoBioMatters Industries S.L.; BASF SE; A. Schulman, Inc.; Clariant AG; and RTP Company. Most companies are making effort to provide superior quality products and to expand their product portfolio. For instance, in September 2016, BASF introduced MasterLife AMA 100, an antimicrobial admixture for improving the protection of concrete structures against damage.